Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dave Singh

Showing results (381-390 of 505) with videos related to

Pageof 51
Sort By:
American Journal of Respiratory and Critical Care Medicine|June 22, 2023
Targeting Type 2 Inflammation and Epithelial Alarmins in Chronic Obstructive Pulmonary Disease: A Biologics OutlookKlaus F Rabe, Stephen Rennard, Fernando J Martinez, et al.
The Lancet. Respiratory Medicine|March 5, 2022
The role of small airway dysfunction in asthma control and exacerbations: a longitudinal, observational analysis using data from the ATLANTIS studyMonica Kraft, Matthew Richardson, Brian Hallmark, et al.
American Journal of Respiratory and Critical Care Medicine|August 30, 2024
Effect of Triple Therapy on Cardiovascular and Severe Cardiopulmonary Events in Chronic Obstructive Pulmonary Disease: A <i>Post Hoc</i> Analysis of a Randomized, Double-Blind, Phase 3 Clinical Trial (ETHOS)Dave Singh, Fernando J Martinez, John R Hurst, et al.
The Journal of Endocrinology|June 28, 2008
Identification and functional analysis of SKA2 interaction with the glucocorticoid receptorLisa Rice, Charlotte E Waters, Jennifer Eccles, et al.
Critical Care (London, England)|July 24, 2020
Nebulised heparin as a treatment for COVID-19: scientific rationale and a call for randomised evidenceFrank M P van Haren, Clive Page, John G Laffey, et al.
BMJ Open Respiratory Research|July 17, 2023
Efficacy and safety of an inhaled pan-Janus kinase inhibitor, nezulcitinib, in hospitalised patients with COVID-19: results from a phase 2 clinical trialJohn Belperio, Tuan Nguyen, David A Lombardi, et al.
The Lancet. Respiratory Medicine|March 17, 2019
Exploring the relevance and extent of small airways dysfunction in asthma (ATLANTIS): baseline data from a prospective cohort studyDirkje S Postma, Chris Brightling, Simonetta Baldi, et al.
Respiratory Research|May 10, 2017
Blood and sputum eosinophils in COPD; relationship with bacterial loadUmme Kolsum, Gavin C Donaldson, Richa Singh, et al.
American Journal of Respiratory and Critical Care Medicine|November 30, 2020
Reduced All-Cause Mortality in the ETHOS Trial of Budesonide/Glycopyrrolate/Formoterol for Chronic Obstructive Pulmonary Disease. A Randomized, Double-Blind, Multicenter, Parallel-Group StudyFernando J Martinez, Klaus F Rabe, Gary T Ferguson, et al.
The New England Journal of Medicine|June 25, 2020
Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPDKlaus F Rabe, Fernando J Martinez, Gary T Ferguson, et al.
Pageof 51

Showing results (381-390 of 505) with videos related to

Sort By:
Pageof 51
American Journal of Respiratory and Critical Care Medicine|June 22, 2023
Targeting Type 2 Inflammation and Epithelial Alarmins in Chronic Obstructive Pulmonary Disease: A Biologics OutlookKlaus F Rabe, Stephen Rennard, Fernando J Martinez, et al.
The Lancet. Respiratory Medicine|March 5, 2022
The role of small airway dysfunction in asthma control and exacerbations: a longitudinal, observational analysis using data from the ATLANTIS studyMonica Kraft, Matthew Richardson, Brian Hallmark, et al.
American Journal of Respiratory and Critical Care Medicine|August 30, 2024
Effect of Triple Therapy on Cardiovascular and Severe Cardiopulmonary Events in Chronic Obstructive Pulmonary Disease: A <i>Post Hoc</i> Analysis of a Randomized, Double-Blind, Phase 3 Clinical Trial (ETHOS)Dave Singh, Fernando J Martinez, John R Hurst, et al.
The Journal of Endocrinology|June 28, 2008
Identification and functional analysis of SKA2 interaction with the glucocorticoid receptorLisa Rice, Charlotte E Waters, Jennifer Eccles, et al.
Critical Care (London, England)|July 24, 2020
Nebulised heparin as a treatment for COVID-19: scientific rationale and a call for randomised evidenceFrank M P van Haren, Clive Page, John G Laffey, et al.
BMJ Open Respiratory Research|July 17, 2023
Efficacy and safety of an inhaled pan-Janus kinase inhibitor, nezulcitinib, in hospitalised patients with COVID-19: results from a phase 2 clinical trialJohn Belperio, Tuan Nguyen, David A Lombardi, et al.
The Lancet. Respiratory Medicine|March 17, 2019
Exploring the relevance and extent of small airways dysfunction in asthma (ATLANTIS): baseline data from a prospective cohort studyDirkje S Postma, Chris Brightling, Simonetta Baldi, et al.
Respiratory Research|May 10, 2017
Blood and sputum eosinophils in COPD; relationship with bacterial loadUmme Kolsum, Gavin C Donaldson, Richa Singh, et al.
American Journal of Respiratory and Critical Care Medicine|November 30, 2020
Reduced All-Cause Mortality in the ETHOS Trial of Budesonide/Glycopyrrolate/Formoterol for Chronic Obstructive Pulmonary Disease. A Randomized, Double-Blind, Multicenter, Parallel-Group StudyFernando J Martinez, Klaus F Rabe, Gary T Ferguson, et al.
The New England Journal of Medicine|June 25, 2020
Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPDKlaus F Rabe, Fernando J Martinez, Gary T Ferguson, et al.
Pageof 51